CN Stock MarketDetailed Quotes

301207 Hualan Biological Vaccine Inc.

Watchlist
  • 20.20
  • +0.49+2.49%
Market Closed Nov 5 15:00 CST
12.14BMarket Cap24.40P/E (TTM)

Hualan Biological Vaccine Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
41.37%531.25M
71.94%1.26B
45.98%623.99M
6.82%640.98M
-58.40%375.78M
-27.94%734.26M
-77.04%427.45M
356.08%600.04M
45.01%903.26M
116.97%1.02B
Transactional financial assets
-28.58%1.35B
-11.52%1.27B
44.47%2.4B
12.63%1.6B
42.37%1.89B
-17.42%1.43B
61.29%1.66B
71.86%1.42B
65.82%1.33B
212.60%1.73B
Notes receivable and accounts receivable
-18.03%1.71B
17.26%1.17B
5.15%1.58B
10.80%1.99B
0.57%2.08B
-47.93%1B
24.30%1.5B
24.84%1.8B
30.04%2.07B
241.70%1.92B
-Accounts receivable
-18.03%1.71B
17.26%1.17B
5.15%1.58B
10.80%1.99B
0.57%2.08B
-47.93%1B
24.30%1.5B
24.84%1.8B
30.04%2.07B
241.70%1.92B
Other receivables (including interest and dividends)
-83.67%596.12K
-81.62%735.4K
-31.78%2.56M
219.16%1.31M
332.65%3.65M
662.36%4M
459.72%3.75M
-79.97%411.02K
-57.82%843.87K
-86.17%524.82K
-Other receivable
----
-81.62%735.4K
----
----
----
662.36%4M
----
-79.97%411.02K
----
-71.05%524.82K
Advance payment
78.10%51.18M
93.34%48.2M
102.47%43.9M
39.37%28.18M
65.73%28.74M
-38.23%24.93M
-76.38%21.68M
-13.27%20.22M
-53.31%17.34M
-3.26%40.36M
Inventories
-16.37%243.83M
-11.16%378.07M
0.05%321.52M
3.78%173.47M
1.70%291.55M
42.36%425.54M
-3.23%321.36M
55.63%167.16M
26.61%286.69M
23.34%298.91M
Receivable financing
--454.29K
--2.06M
----
----
----
----
----
----
----
----
Non-current assets due within one year
77.71%659.85M
-17.92%303M
166.77%346.81M
187.28%373.46M
--371.3M
--369.14M
--130M
--130M
----
----
Other current assets
--89.45M
-39.56%9.63M
----
610.54%420.39M
----
--15.93M
-97.71%1.87K
59,524.87%59.17M
----
----
Total current assets
-8.12%4.63B
10.94%4.44B
30.76%5.31B
24.66%5.23B
9.47%5.04B
-20.11%4.01B
-10.14%4.06B
65.77%4.19B
40.36%4.6B
167.43%5.01B
Non Current assets
Fixed assets
----
-9.69%1.11B
----
----
----
-6.23%1.23B
----
-4.82%1.28B
----
123.46%1.31B
Constru in process
----
24.09%4.09M
----
----
----
578.94%3.3M
----
--3.26M
----
-99.89%485.75K
Productive biological assets
-45.45%856.33K
----
54.95%367.15K
49.03%965.1K
16.26%1.57M
-45.48%349K
-60.08%236.94K
-58.70%647.59K
-46.79%1.35M
0.79%640.15K
Intangible assets
-3.22%19.64M
-3.19%19.8M
-3.17%19.96M
-3.14%20.13M
-3.12%20.29M
-3.09%20.45M
-3.07%20.62M
-3.05%20.78M
-3.02%20.94M
-3.00%21.11M
Development expenditure
7.23%27.64M
9.68%27.44M
10.87%26.92M
8.71%26.27M
7.59%25.77M
7.70%25.02M
5.55%24.28M
7.27%24.16M
7.98%23.95M
6.01%23.23M
Long deferred expense
--417.31K
-43.35%834.63K
-58.29%1.25M
-63.15%1.67M
----
-80.52%1.47M
-72.28%3M
-58.17%4.53M
-38.40%7.59M
--7.56M
Deferred tax assets
-13.78%180.52M
8.09%216.47M
6.91%212.59M
4.51%217.97M
6.04%209.38M
1.25%200.28M
4.73%198.84M
14.03%208.56M
14.78%197.46M
4.17%197.8M
Usufruct assets
----
----
----
----
----
----
----
----
-50.00%1.02M
-44.44%1.28M
Other non current assets
29.77%1.69B
10.03%1.44B
-28.94%1.09B
-0.83%1.33B
26.49%1.3B
88.13%1.31B
134.37%1.53B
230.14%1.34B
456.27%1.03B
307.39%694.71M
Total non current assets
8.79%3.01B
1.07%2.82B
-17.87%2.5B
-3.96%2.77B
7.70%2.77B
23.46%2.79B
36.61%3.04B
44.56%2.88B
73.39%2.57B
57.28%2.26B
Total assets
-2.13%7.64B
6.89%7.26B
9.95%7.81B
13.00%8B
8.84%7.81B
-6.58%6.79B
5.28%7.1B
56.42%7.08B
50.63%7.17B
119.68%7.27B
Liabilities
Current liabilities
Short term loan
0.00%300M
0.00%300M
0.00%300M
0.00%300.18M
0.00%300M
-40.00%300M
-40.00%300M
-40.02%300.18M
-62.50%300M
66.67%500M
Notes payable and accounts payable
-34.69%79.73M
-21.29%106.42M
-5.33%142.91M
-7.09%116.76M
-14.50%122.07M
-26.07%135.22M
-47.31%150.95M
-32.25%125.67M
2.58%142.77M
38.03%182.9M
-Notes payable
120.68%6.91M
-35.10%12.01M
97.21%19.86M
----
-84.49%3.13M
101.66%18.51M
-81.50%10.07M
-36.61%15.31M
-39.16%20.18M
-84.28%9.18M
-Accounts payable
-38.78%72.82M
-19.10%94.41M
-12.66%123.04M
5.80%116.76M
-2.97%118.94M
-32.82%116.7M
-39.29%140.88M
-31.60%110.36M
15.64%122.59M
134.36%173.72M
Contract liabilities
12.03%6.92M
215.82%14.53M
103.91%6.87M
-0.41%2.67M
91.46%6.18M
32.31%4.6M
88.35%3.37M
74.10%2.68M
119.44%3.23M
82.88%3.48M
Salaries payable
----
----
--45.39K
----
----
--3.54K
----
----
----
----
Taxs payable
-90.74%7.79M
-16.39%2.07M
-72.26%2.29M
347.32%57.68M
102.92%84.2M
-97.16%2.47M
12.29%8.26M
-49.79%12.89M
-59.15%41.5M
9,015.25%87.22M
Other payable (including interest and dividends)
-9.20%1.11B
8.92%877.23M
0.62%1B
10.30%1.21B
4.70%1.22B
-31.90%805.42M
16.84%998.58M
14.85%1.1B
22.04%1.17B
77.41%1.18B
-Dividend payable
--28.55M
--28.55M
----
----
----
----
----
----
----
----
-Other payable
----
5.37%848.67M
----
----
----
-31.90%805.42M
----
14.85%1.1B
----
77.41%1.18B
Non current liabilities due within one year
----
----
----
----
----
----
----
----
4.75%1.07M
4.75%1.06M
Other current liabilities
12.02%207.56K
216.09%435.72K
104.05%205.92K
0.14%80.09K
93.35%185.28K
36.86%137.84K
88.36%100.91K
75.01%79.97K
117.50%95.83K
82.61%100.72K
Total current liabilities
-13.29%1.5B
4.23%1.3B
-0.29%1.46B
9.68%1.69B
4.76%1.73B
-36.25%1.25B
-11.51%1.46B
-8.09%1.54B
-17.38%1.65B
76.79%1.96B
Current liabilities
Deferred tax liabilities
15.01%15.9M
30.94%13.61M
67.62%14.56M
137.44%15.22M
233.73%13.83M
176.34%10.39M
188.80%8.69M
156.71%6.41M
115.77%4.14M
133.62%3.76M
Long term deferred income
-13.04%28.25M
-12.62%29.31M
-12.24%30.36M
-11.87%31.42M
-14.01%32.48M
-11.21%33.54M
-13.27%34.6M
-10.61%35.66M
-7.87%37.77M
-7.87%37.77M
Lease liabilities
----
----
----
----
----
----
----
----
----
-79.53%271.83K
Total non current liabilities
-4.66%44.15M
-2.32%42.91M
3.79%44.92M
10.88%46.64M
10.48%46.31M
5.08%43.93M
-0.35%43.28M
-2.61%42.07M
-4.71%41.92M
-4.85%41.81M
Total liabilities
-13.06%1.55B
4.01%1.34B
-0.17%1.5B
9.71%1.73B
4.90%1.78B
-35.38%1.29B
-11.23%1.5B
-7.95%1.58B
-17.11%1.7B
73.67%2B
Shareholders equity
Paid-in capital
0.17%601.03M
0.17%601.03M
50.00%600.02M
50.00%600.02M
50.00%600.02M
50.00%600.02M
0.00%400.01M
11.11%400.01M
11.11%400.01M
11.11%400.01M
Capital reserve funds
1.18%2.94B
1.28%2.94B
-5.66%2.92B
-5.62%2.92B
-5.63%2.91B
-5.87%2.9B
0.38%3.1B
251.06%3.09B
250.54%3.08B
250.54%3.08B
Surplus reserve funds
43.07%286.16M
43.07%286.16M
43.07%286.16M
43.07%286.16M
27.44%200.01M
27.44%200.01M
27.44%200.01M
27.44%200.01M
65.71%156.94M
65.71%156.94M
Retained profit
2.22%2.37B
18.42%2.13B
31.47%2.5B
36.16%2.46B
26.23%2.32B
10.22%1.8B
34.84%1.9B
28.10%1.81B
32.97%1.84B
97.85%1.63B
Less:Treasury stock
--106.79M
--38.75M
----
----
----
----
----
----
----
----
Shareholders equity without minority interests
1.10%6.09B
7.57%5.92B
12.67%6.31B
13.95%6.26B
10.06%6.03B
4.34%5.5B
10.81%5.6B
95.74%5.5B
101.71%5.48B
144.21%5.27B
Total shareholder equity
1.10%6.09B
7.57%5.92B
12.67%6.31B
13.95%6.26B
10.06%6.03B
4.34%5.5B
10.81%5.6B
95.74%5.5B
101.71%5.48B
144.21%5.27B
Total liabilityies and equity
-2.13%7.64B
6.89%7.26B
9.95%7.81B
13.00%8B
8.84%7.81B
-6.58%6.79B
5.28%7.1B
56.42%7.08B
50.63%7.17B
119.68%7.27B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 41.37%531.25M71.94%1.26B45.98%623.99M6.82%640.98M-58.40%375.78M-27.94%734.26M-77.04%427.45M356.08%600.04M45.01%903.26M116.97%1.02B
Transactional financial assets -28.58%1.35B-11.52%1.27B44.47%2.4B12.63%1.6B42.37%1.89B-17.42%1.43B61.29%1.66B71.86%1.42B65.82%1.33B212.60%1.73B
Notes receivable and accounts receivable -18.03%1.71B17.26%1.17B5.15%1.58B10.80%1.99B0.57%2.08B-47.93%1B24.30%1.5B24.84%1.8B30.04%2.07B241.70%1.92B
-Accounts receivable -18.03%1.71B17.26%1.17B5.15%1.58B10.80%1.99B0.57%2.08B-47.93%1B24.30%1.5B24.84%1.8B30.04%2.07B241.70%1.92B
Other receivables (including interest and dividends) -83.67%596.12K-81.62%735.4K-31.78%2.56M219.16%1.31M332.65%3.65M662.36%4M459.72%3.75M-79.97%411.02K-57.82%843.87K-86.17%524.82K
-Other receivable -----81.62%735.4K------------662.36%4M-----79.97%411.02K-----71.05%524.82K
Advance payment 78.10%51.18M93.34%48.2M102.47%43.9M39.37%28.18M65.73%28.74M-38.23%24.93M-76.38%21.68M-13.27%20.22M-53.31%17.34M-3.26%40.36M
Inventories -16.37%243.83M-11.16%378.07M0.05%321.52M3.78%173.47M1.70%291.55M42.36%425.54M-3.23%321.36M55.63%167.16M26.61%286.69M23.34%298.91M
Receivable financing --454.29K--2.06M--------------------------------
Non-current assets due within one year 77.71%659.85M-17.92%303M166.77%346.81M187.28%373.46M--371.3M--369.14M--130M--130M--------
Other current assets --89.45M-39.56%9.63M----610.54%420.39M------15.93M-97.71%1.87K59,524.87%59.17M--------
Total current assets -8.12%4.63B10.94%4.44B30.76%5.31B24.66%5.23B9.47%5.04B-20.11%4.01B-10.14%4.06B65.77%4.19B40.36%4.6B167.43%5.01B
Non Current assets
Fixed assets -----9.69%1.11B-------------6.23%1.23B-----4.82%1.28B----123.46%1.31B
Constru in process ----24.09%4.09M------------578.94%3.3M------3.26M-----99.89%485.75K
Productive biological assets -45.45%856.33K----54.95%367.15K49.03%965.1K16.26%1.57M-45.48%349K-60.08%236.94K-58.70%647.59K-46.79%1.35M0.79%640.15K
Intangible assets -3.22%19.64M-3.19%19.8M-3.17%19.96M-3.14%20.13M-3.12%20.29M-3.09%20.45M-3.07%20.62M-3.05%20.78M-3.02%20.94M-3.00%21.11M
Development expenditure 7.23%27.64M9.68%27.44M10.87%26.92M8.71%26.27M7.59%25.77M7.70%25.02M5.55%24.28M7.27%24.16M7.98%23.95M6.01%23.23M
Long deferred expense --417.31K-43.35%834.63K-58.29%1.25M-63.15%1.67M-----80.52%1.47M-72.28%3M-58.17%4.53M-38.40%7.59M--7.56M
Deferred tax assets -13.78%180.52M8.09%216.47M6.91%212.59M4.51%217.97M6.04%209.38M1.25%200.28M4.73%198.84M14.03%208.56M14.78%197.46M4.17%197.8M
Usufruct assets ---------------------------------50.00%1.02M-44.44%1.28M
Other non current assets 29.77%1.69B10.03%1.44B-28.94%1.09B-0.83%1.33B26.49%1.3B88.13%1.31B134.37%1.53B230.14%1.34B456.27%1.03B307.39%694.71M
Total non current assets 8.79%3.01B1.07%2.82B-17.87%2.5B-3.96%2.77B7.70%2.77B23.46%2.79B36.61%3.04B44.56%2.88B73.39%2.57B57.28%2.26B
Total assets -2.13%7.64B6.89%7.26B9.95%7.81B13.00%8B8.84%7.81B-6.58%6.79B5.28%7.1B56.42%7.08B50.63%7.17B119.68%7.27B
Liabilities
Current liabilities
Short term loan 0.00%300M0.00%300M0.00%300M0.00%300.18M0.00%300M-40.00%300M-40.00%300M-40.02%300.18M-62.50%300M66.67%500M
Notes payable and accounts payable -34.69%79.73M-21.29%106.42M-5.33%142.91M-7.09%116.76M-14.50%122.07M-26.07%135.22M-47.31%150.95M-32.25%125.67M2.58%142.77M38.03%182.9M
-Notes payable 120.68%6.91M-35.10%12.01M97.21%19.86M-----84.49%3.13M101.66%18.51M-81.50%10.07M-36.61%15.31M-39.16%20.18M-84.28%9.18M
-Accounts payable -38.78%72.82M-19.10%94.41M-12.66%123.04M5.80%116.76M-2.97%118.94M-32.82%116.7M-39.29%140.88M-31.60%110.36M15.64%122.59M134.36%173.72M
Contract liabilities 12.03%6.92M215.82%14.53M103.91%6.87M-0.41%2.67M91.46%6.18M32.31%4.6M88.35%3.37M74.10%2.68M119.44%3.23M82.88%3.48M
Salaries payable ----------45.39K----------3.54K----------------
Taxs payable -90.74%7.79M-16.39%2.07M-72.26%2.29M347.32%57.68M102.92%84.2M-97.16%2.47M12.29%8.26M-49.79%12.89M-59.15%41.5M9,015.25%87.22M
Other payable (including interest and dividends) -9.20%1.11B8.92%877.23M0.62%1B10.30%1.21B4.70%1.22B-31.90%805.42M16.84%998.58M14.85%1.1B22.04%1.17B77.41%1.18B
-Dividend payable --28.55M--28.55M--------------------------------
-Other payable ----5.37%848.67M-------------31.90%805.42M----14.85%1.1B----77.41%1.18B
Non current liabilities due within one year --------------------------------4.75%1.07M4.75%1.06M
Other current liabilities 12.02%207.56K216.09%435.72K104.05%205.92K0.14%80.09K93.35%185.28K36.86%137.84K88.36%100.91K75.01%79.97K117.50%95.83K82.61%100.72K
Total current liabilities -13.29%1.5B4.23%1.3B-0.29%1.46B9.68%1.69B4.76%1.73B-36.25%1.25B-11.51%1.46B-8.09%1.54B-17.38%1.65B76.79%1.96B
Current liabilities
Deferred tax liabilities 15.01%15.9M30.94%13.61M67.62%14.56M137.44%15.22M233.73%13.83M176.34%10.39M188.80%8.69M156.71%6.41M115.77%4.14M133.62%3.76M
Long term deferred income -13.04%28.25M-12.62%29.31M-12.24%30.36M-11.87%31.42M-14.01%32.48M-11.21%33.54M-13.27%34.6M-10.61%35.66M-7.87%37.77M-7.87%37.77M
Lease liabilities -------------------------------------79.53%271.83K
Total non current liabilities -4.66%44.15M-2.32%42.91M3.79%44.92M10.88%46.64M10.48%46.31M5.08%43.93M-0.35%43.28M-2.61%42.07M-4.71%41.92M-4.85%41.81M
Total liabilities -13.06%1.55B4.01%1.34B-0.17%1.5B9.71%1.73B4.90%1.78B-35.38%1.29B-11.23%1.5B-7.95%1.58B-17.11%1.7B73.67%2B
Shareholders equity
Paid-in capital 0.17%601.03M0.17%601.03M50.00%600.02M50.00%600.02M50.00%600.02M50.00%600.02M0.00%400.01M11.11%400.01M11.11%400.01M11.11%400.01M
Capital reserve funds 1.18%2.94B1.28%2.94B-5.66%2.92B-5.62%2.92B-5.63%2.91B-5.87%2.9B0.38%3.1B251.06%3.09B250.54%3.08B250.54%3.08B
Surplus reserve funds 43.07%286.16M43.07%286.16M43.07%286.16M43.07%286.16M27.44%200.01M27.44%200.01M27.44%200.01M27.44%200.01M65.71%156.94M65.71%156.94M
Retained profit 2.22%2.37B18.42%2.13B31.47%2.5B36.16%2.46B26.23%2.32B10.22%1.8B34.84%1.9B28.10%1.81B32.97%1.84B97.85%1.63B
Less:Treasury stock --106.79M--38.75M--------------------------------
Shareholders equity without minority interests 1.10%6.09B7.57%5.92B12.67%6.31B13.95%6.26B10.06%6.03B4.34%5.5B10.81%5.6B95.74%5.5B101.71%5.48B144.21%5.27B
Total shareholder equity 1.10%6.09B7.57%5.92B12.67%6.31B13.95%6.26B10.06%6.03B4.34%5.5B10.81%5.6B95.74%5.5B101.71%5.48B144.21%5.27B
Total liabilityies and equity -2.13%7.64B6.89%7.26B9.95%7.81B13.00%8B8.84%7.81B-6.58%6.79B5.28%7.1B56.42%7.08B50.63%7.17B119.68%7.27B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data